Home Pain mechanisms in animal models of rheumatoid arthritis
Article Publicly Available

Pain mechanisms in animal models of rheumatoid arthritis

  • Christina Christianson , Duygu BalkisBas , Rikard Holmdahl , Nandakumar Kutty Selva , Tony Yaksh , Maripat Corr , Gary Firestein and Camilla I. Svensson
Published/Copyright: July 1, 2010
Become an author with De Gruyter Brill

Rheumatoid arthritis (RA) is chronic disease affecting 1% of the population. It is characterized by infiltration of inflammatory cells into the joints, synovial neovascularization and proliferation of fibroblasts and bone erosion. Clinically the disease is evident as joint inflammation, swelling and progressive joint destruction. Of importance, pain is one of the most bothersome symptoms reported by RA patients. Autoantibodies to type II collagen (CII) and glucose-6- phosphate isomerase (GPI) are detected in serum of 70% and 20% of the RA patients, respectively. Intraperitoneal injection of these antibodies to mice rapidly induces arthritis-like symptoms and generates a joint pathology that resembles human RA. While collagen antibody-induced arthritis (CAIA) and K/BxN serum transfer (GPI antibody-mediated) are common models in the rheumatology field, they have not been evaluated as models of arthritis-induced pain. Data from our studies in which pain behavior (tactile and cold allodynia) and the analgesic effect of ketorolac (cyclooxygenase inhibitor), etanercept (TNF inhibitor) and gabapentin were examined will be presented. In brief, we observed that both injection of CII and GPI antibodies caused induction of clinical signs of arthritis including joint swelling and redness of the paws, and that this inflammatory state gave rise to a robust, and reproducible allodynia. Interestingly, the allodynia outlasted the signs of joint inflammation. Of note, while intraperitoneal injection of ketorolac, etanercept and gapapentin attenuated arthritis-induced allodynia during the inflammatory phase, only gabapentin had antiallodynic effect in the “post-inflammatory” phase. Spinal activation of astrocytes and microglia was assessed as these cells have been implicated to play a role in the maintenance of hypersensitivity in experimental models of persistent pain. Experiments in which microglia and astrocyte activity was assessed using quantitative real time PCR and immunohistochemistry indicated activation of spinal glia in both models.

In summary, our work demonstrates that the CAIA and K/BxN arthritis models generate robust and highly reproducible allodynia. Based on the resemblance with human pathology these models may become important assets in dissecting the mechanisms that drive arthritis-induced pain, both during peak and remittent phases of the disease.

Supported by: Swedish Research Council, Reumatikerförbundet, Swedish foundation for strategic research, Olle Engkvist byggmästare foundation, International Association for Studies of Pain, EU - Marie Curie and NIH.

Published Online: 2010-07-01
Published in Print: 2010-07-01

© 2010 Scandinavian Association for the Study of Pain

Articles in the same Issue

  1. Editorial comment
  2. Functional brain imaging of acute postoperative pain
  3. Clinical pain research
  4. Brain activation due to postoperative pain from the right hand measured with regional cerebral blood flow using positron emission tomography
  5. Editorial comment
  6. Long-term low-dose transdermal buprenorphine therapy for chronic noncancer pain
  7. Original experimental
  8. A 6-months, randomised, placebo-controlled evaluation of efficacy and tolerability of a low-dose 7-day buprenorphine transdermal patch in osteoarthritis patients naïve to potent opioids
  9. Editorial comment
  10. Repeated nociceptive stimulation for detecting drug effects
  11. Original experimental
  12. The effects of gabapentin in human experimental pain models
  13. Editorial comment
  14. Whether the weather influences pain: High prevalence of chronic pain in Iceland and Norway: Common genes? Or lack of sunshine and vitamin D?
  15. Observational studies
  16. A population based study of the prevalence of pain in Iceland
  17. Editorial comment
  18. Swedish nurses are prone to chronic shoulder and back pain because of miserable working conditions and poor leadership?
  19. Observational studies
  20. Predicting of pain, disability, and sick leave regarding a non-clinical sample among Swedish nurses
  21. Abstracts
  22. Trigeminal neuralgia or odontogenic pain
  23. Abstracts
  24. What’s wrong with animal models of pain?
  25. Abstracts
  26. Immunotherapy for neuroblastoma elicits a complement dependent whole body allodynia
  27. Abstracts
  28. Pain mechanisms in animal models of rheumatoid arthritis
  29. Abstracts
  30. Translating basic research to pharmacological treatment of neuropathic pain
  31. Abstracts
  32. Free Poster Presentations: Forearm heat pain does not inhibit electrically induced tibialis anterior muscle pain
  33. Abstracts
  34. Offset analgesia evoked by non-contact thermal stimulator
  35. Abstracts
  36. Inhibition of FAAH reverses spinal LTP
  37. Abstracts
  38. Hyperexcitable C-nociceptors in human paroxysmal pain
  39. Abstracts
  40. Pain sensitivity and experimentally induced sensitization in red haired women
  41. Abstracts
  42. How are opioids used in Norway? Persistent use, utilization of depot formulation and age profile in non-palliation patients
  43. Abstracts
  44. To which extent does incident and persistent use of weak opioids predict problematic opioid use?
  45. Abstracts
  46. Is transdermal buprenorphine for chronic non-malignant pain used long term without co-medication with other potentially addictive drugs?
  47. Abstracts
  48. Prostaglandin E2 production in synovial tissue and acute postoperative pain after knee arthroscopy
  49. Abstracts
  50. Girl presenting with oesophageal spasm pain after fundoplication
  51. Abstracts
  52. Epidemiology of persistent postoperative pain: Association of persistent pain and sensory abnormalities
  53. Abstracts
  54. Cost–benefit of a 13-week multidiciplinary rehabilitation course for chronic non-malignant pain patients
  55. Abstracts
  56. A novel and effective treatment modality for medically unexplained pain
  57. Abstracts
  58. Somatocognitive therapy in the management of chronic gynaecological pain. A review of current approach and historical background
  59. Abstract
  60. The Manual Intervention Trial (MINT)—The effect of various combinations of naprapathic manual therapy. The study protocol of a randomized controlled trial
  61. Abstracts
  62. The experience of chronic pain, loss and grief
  63. Abstracts
  64. Effect of buprenorphine and fentanyl in experimental induced superficial, deep and hyperalgesic pain
  65. Abstract
  66. Pretreatment with opioids enhances afferent induced long-term potentiation in the rat dorsal horn
  67. Abstracts
  68. Pigs in pain—Porcine behavioural responses towards mechanical nociceptive stimulation directed at the hind legs
  69. Abstracts
  70. A human experimental bone pain model
Downloaded on 30.9.2025 from https://www.degruyterbrill.com/document/doi/10.1016/j.sjpain.2010.05.006/html?lang=en
Scroll to top button